Obscurin anticorps (AA 1621-1712) (HRP)
-
- Antigène Voir toutes Obscurin (OBSCN) Anticorps
- Obscurin (OBSCN)
-
Épitope
- AA 1621-1712
- Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Obscurin est conjugé à/à la HRP
-
Application
- ELISA
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Obscurin protein (1621-1712AA)
- Isotype
- IgG
- Top Product
- Discover our top product OBSCN Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- Obscurin (OBSCN)
- Autre désignation
- OBSCN (OBSCN Produits)
- Synonymes
- anticorps ARHGEF30, anticorps UNC89, anticorps BC046431, anticorps Gm878, anticorps OTTMUSG00000005786, anticorps obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF, anticorps OBSCN, anticorps Obscn
- Sujet
-
Background: Structural component of striated muscles which plays a role in myofibrillogenesis. Probably involved in the assembly of myosin into sarcomeric A bands in striated muscle (PubMed:11448995, PubMed:16205939). Has serine/threonine protein kinase activity and phosphorylates N-cadherin CDH2 and sodium/potassium-transporting ATPase subunit ATP1B1 (By similarity).
Aliases: BC046431 antibody, Gm878 antibody, KIAA1556 antibody, KIAA1639 antibody, OBSCN antibody, OBSCN_HUMAN antibody, Obscurin antibody, Obscurin-MLCK antibody, Obscurin-myosin light chain kinase antibody, Obscurin-RhoGEF antibody, OTTMUSG00000005786 antibody, UNC89 antibody
- UniProt
- Q5VST9
- Pathways
- Neurotrophin Signaling Pathway
-